ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NURO NeuroMetrix Inc

3.69
-0.03 (-0.81%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 3,508
Bid Price 2.00
Ask Price 12.24
News -
Day High 3.8399

Low
2.70

52 Week Range

High
9.20

Day Low 3.66
Share Name Share Symbol Market Stock Type
NeuroMetrix Inc NURO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.03 -0.81% 3.69 23:00:07
Open Price Low Price High Price Close Price Previous Close
3.66 3.66 3.8399 3.69 3.72
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
82 3,508 US$ 3.76 US$ 13,186 - 2.70 - 9.20
Last Trade Type Quantity Price Currency
15:00:00 18 US$ 3.70 USD

NeuroMetrix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.33M 1.99M - 5.9M -6.53M -3.29 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NeuroMetrix News

Date Time Source News Article
5/31/202412:15Edgar (US Regulatory)Form SD - Specialized disclosure report
5/24/202416:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/24/202416:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/24/202416:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/15/202415:00GlobeNewswire Inc.NeuroMetrix Reports Q1 2024 Business Highlights
5/15/202411:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
5/15/202410:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/07/202415:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
4/19/202407:00GlobeNewswire Inc.NeuroMetrix Announces Steps Taken to Enhance Shareholder..
3/14/202408:00GlobeNewswire Inc.NeuroMetrix Announces Publication of Study Demonstrating..
3/13/202408:00GlobeNewswire Inc.NeuroMetrix announces that over 2000 patients with..
3/06/202416:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NURO Message Board. Create One! See More Posts on NURO Message Board See More Message Board Posts

Historical NURO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.803.873.663.816,780-0.11-2.89%
1 Month4.054.083.643.836,872-0.36-8.89%
3 Months4.084.703.514.2017,927-0.39-9.56%
6 Months3.554.702.703.6537,3950.143.94%
1 Year8.569.202.705.2653,027-4.87-56.89%
3 Years28.00310.002.7095.001,241,711-24.31-86.82%
5 Years4.24310.002.014479.33944,357-0.55-12.97%

NeuroMetrix Description

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.

Your Recent History